Hosted on MSN35m
What To Expect When IBD 50's No. 2, Hims & Hers, Reports Amid The Semaglutide Battle
Compounding pharmacy and IBD 50 newcomer Hims & Hers Health is expected late Monday to report bullish earnings and sales ...
Robinhood says a SEC crypto investigation is over
Robinhood said the SEC ended an investigation into its crypto unit, in what appears to be another move by the Trump ...
24/7 Wall St. on MSN6m
HIMS is Out. Is Novo Nordisk or Eli Lilly the Better GLP-1 Buy?
The Food & Drug Administration announced last week that the Ozempic and Wegovy shortage for Novo Nordisk's (NYSE:NVO) was ...